These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin. Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610 [TBL] [Abstract][Full Text] [Related]
4. AC133 antigen as a prognostic factor in acute leukemia. Lee ST; Jang JH; Min YH; Hahn JS; Ko YW Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469 [TBL] [Abstract][Full Text] [Related]
5. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162 [TBL] [Abstract][Full Text] [Related]
6. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma. Lemoli RM; Cavo M; Fortuna A J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic profile of AC133-positive cells in bone marrow, mobilized peripheral blood and umbilical cord blood. D'Arena G; Savino L; Nunziata G; Cascavilla N; Matera R; Pistolese G; Carella AM Leuk Lymphoma; 2002 Apr; 43(4):869-73. PubMed ID: 12153177 [TBL] [Abstract][Full Text] [Related]
8. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells. Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669 [TBL] [Abstract][Full Text] [Related]
9. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674 [TBL] [Abstract][Full Text] [Related]
10. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients. Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576 [TBL] [Abstract][Full Text] [Related]
11. Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation. Yasui K; Matsumoto K; Hirayama F; Tani Y; Nakano T Stem Cells; 2003; 21(2):143-51. PubMed ID: 12634410 [TBL] [Abstract][Full Text] [Related]
12. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Case J; Mead LE; Bessler WK; Prater D; White HA; Saadatzadeh MR; Bhavsar JR; Yoder MC; Haneline LS; Ingram DA Exp Hematol; 2007 Jul; 35(7):1109-18. PubMed ID: 17588480 [TBL] [Abstract][Full Text] [Related]
13. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. Steen R; Tjønnfjord GE; Egeland T J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606 [TBL] [Abstract][Full Text] [Related]
16. [Mobilization effects of SCF along with G-CSF on bone marrow stem cells and endothelial progenitor cells in rats with unilateral ureteral obstruction]. Zhang JJ; Yi ZW; Dang XQ; He XJ; Wu XC Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):144-8. PubMed ID: 17448311 [TBL] [Abstract][Full Text] [Related]
17. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants. Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405 [TBL] [Abstract][Full Text] [Related]
18. A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34(bright) and AC133(dim/)-CD34+ human cord blood cells. Goussetis E; Theodosaki M; Paterakis G; Peristeri J; Petropoulos D; Kitra V; Papassarandis C; Graphakos S J Hematother Stem Cell Res; 2000 Dec; 9(6):827-40. PubMed ID: 11177594 [TBL] [Abstract][Full Text] [Related]
19. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells . Haas R; Murea S Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Gallacher L; Murdoch B; Wu DM; Karanu FN; Keeney M; Bhatia M Blood; 2000 May; 95(9):2813-20. PubMed ID: 10779426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]